New mutations in the KVLQT1 potassium channel that cause long-QT syndrome

被引:68
|
作者
Li, H
Chen, QY
Moss, AJ
Robinson, J
Goytia, V
Perry, JC
Vincent, GM
Priori, SG
Lehmann, MH
Denfield, SW
Duff, D
Kaine, S
Shimizu, W
Schwartz, PJ
Wang, Q
Towbin, JA
机构
[1] Baylor Coll Med, Dept Pediat, Lillie Frank Abercrombie Sect Pediat Cardiol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[3] Childrens Hosp & Hlth Ctr, San Diego, CA USA
[4] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA
[5] LDS Hosp, Dept Med, Salt Lake City, UT USA
[6] Univ Utah, Sch Med, Salt Lake City, UT USA
[7] Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy
[8] IFCCS, Policlin San Matteo, Pavia, Italy
[9] Wayne State Univ, Sinai Hosp, Sch Med, Arrhythmia Ctr, Detroit, MI USA
[10] Our Ladys Hosp Sick Children, Dublin, Ireland
[11] Childrens Mercy Hosp, Kansas City, MO 64108 USA
[12] Natl Cardiovasc Ctr, Osaka, Japan
关键词
arrhythmias; long-QT syndrome; potassium; death; sudden; KVLQT1;
D O I
10.1161/01.CIR.97.13.1264
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Long-QT syndrome (LQTS) is an inherited cardiac arrhythmia that causes sudden death in young, otherwise healthy people. Four genes for LQTS have been mapped to chromosome 11p15.5 (LQT1), 7q35-36 (LQT2), 3p21-24 (LQT3), and 4q25-27 (LQT4). Genes responsible for LQT1, LQT2, and LQT3 have been identified as cardiac potassium channel genes (KVLQT1, HERG) and the cardiac sodium channel gene (SCN5A). Methods and Results-After studying 115 families with LQTS, we used single-strand conformation polymorphism (SSCP) and DNA sequence analysis to identify mutations in the cardiac potassium channel gene, KVLQT1. Affected members of seven LQTS families were found to have new, previously unidentified mutations, including two identical missense mutations, four identical splicing mutations, and one 3-bp deletion. An identical splicing mutation was identified in affected members of four unrelated families (one Italian, one Irish, and two American), leading to an alternatively spliced form of KVLQT1. The 3-bp deletion arose de novo and occurs at an exon-intron boundary. This results in a single base deletion in the KVLQT1 cDNA sequence and alters splicing, leading to the truncation of KVLQT1 protein. Conclusions-We have identified LQTS-causing mutations of KVLQT1 in seven families. Five KVLQT1 mutations cause the truncation of KVLQT1 protein. These data further confirm that KVLQT1 mutations cause LQTS. The location and character of these mutations expand the types of mutation, confirm a mutational hot spot, and suggest that they act through a loss-of-function mechanism or a dominant-negative mechanism.
引用
收藏
页码:1264 / 1269
页数:6
相关论文
共 50 条
  • [31] High Efficacy of β-Blockers in Long-QT Syndrome Type 1 Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of β-Blocker Treatment "Failures"
    Vincent, G. Michael
    Schwartz, Peter J.
    Denjoy, Isabelle
    Swan, Heikki
    Bithell, Candice
    Spazzolini, Carla
    Crotti, Lia
    Piippo, Kirsi
    Lupoglazoff, Jean-Marc
    Villain, Elizabeth
    Priori, Silvia G.
    Napolitano, Carlo
    Zhang, Li
    CIRCULATION, 2009, 119 (02) : 215 - 221
  • [32] Long-QT syndrome presented as epilepsy
    Medina-Villanueva, A
    Rey-Galán, R
    Concha-Torre, A
    Gutiérrez-Martínez, R
    REVISTA DE NEUROLOGIA, 2002, 35 (04) : 346 - 348
  • [33] Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel
    Moss, AJ
    Zareba, W
    Kaufman, ES
    Gartman, E
    Peterson, DR
    Benhorin, J
    Towbin, JA
    Keating, MT
    Priori, SG
    Schwartz, PJ
    Vincent, GM
    Robinson, JL
    Andrews, ML
    Feng, CY
    Hall, WJ
    Medina, A
    Zhang, L
    Wang, ZQ
    CIRCULATION, 2002, 105 (07) : 794 - 799
  • [34] HETEROGENEITY IN THE INHERITED LONG-QT SYNDROME
    VINCENT, GM
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1995, 6 (02) : 137 - 146
  • [35] Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland
    Fodstad, H
    Swan, H
    Laitinen, P
    Piippo, K
    Paavonen, K
    Viitasalo, M
    Toivonen, L
    Kontula, K
    ANNALS OF MEDICINE, 2004, 36 : 53 - 63
  • [36] Long-QT Syndrome and Competitive Sports
    Schnell, Frederic
    Behar, Nathalie
    Carre, Francois
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2018, 7 (03) : 187 - 192
  • [37] What Is the Best Age for Diagnostic Prediction of Pediatric Long-QT Syndrome With a Borderline QT Interval?
    Miyazaki, Aya
    Doi, Hiraku
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (04)
  • [38] To Be or Not to Be Long-QT Syndrome Type 9
    Cutler, Michael J.
    Kaufman, Elizabeth S.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2013, 6 (05): : 439 - 440
  • [39] Therapeutic Strategies for Long-QT Syndrome Does the Molecular Substrate Matter?
    Ruan, Yanfei
    Liu, Nian
    Napolitano, Carlo
    Priori, Silvia G.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2008, 1 (04) : 290 - 297
  • [40] Genomic organization of the KCNQ1 K+ channel gene and identification of C-terminal mutations in the long-QT syndrome
    Neyroud, N
    Richard, P
    Vignier, N
    Donger, C
    Denjoy, I
    Demay, L
    Shkolnikova, M
    Pesce, R
    Chevalier, P
    Hainque, B
    Coumel, P
    Schwartz, K
    Guicheney, P
    CIRCULATION RESEARCH, 1999, 84 (03) : 290 - 297